Hopital Ambroise Pare

The Pain Assessment and Treatment Centre at Hopital Ambroise Pare is actively exploring therapies for inflammatory joint conditions, with a focus on improving function and reducing pain for patients with axial spondyloarthritis.

• Evaluation of new anti‑inflammatory agents
• Assessment of disease activity scores
• Improving patient‑reported outcomes

Ongoing research aims to provide clearer treatment pathways and enhance quality of life for individuals living with musculoskeletal disorders.

Clinical investigations at the centre address a range of cancers, including non‑small cell lung cancer, melanoma, and cutaneous squamous cell carcinoma, testing innovative drug combinations and targeted approaches.

• Combination immunotherapy strategies
• Targeted therapy for EGFR exon 20 insertions
• Adjuvant treatment after surgical resection

These studies seek to expand therapeutic options and improve long‑term survival for cancer patients.

The site’s expertise in pain management supports trials targeting chronic peripheral neuropathic pain from post‑herpetic neuralgia and peripheral nerve injury, as well as central neuropathic pain following stroke.

• Novel analgesic delivery methods
• Pain intensity monitoring techniques
• Quality‑of‑life assessments for neuropathic pain sufferers

By evaluating new therapies, the centre aims to reduce suffering and restore daily function for individuals with complex pain conditions.